For patients with T3a disease, 5-year CSS and OS benefit with extended lymphadenectomy did not reach statistical significance (CSS: hazard ratio [HR] 0.98, 95% confidence interval [CI] 0.77–1.24; OS: HR 0.96, 95% CI 0.77–1.20).
← all excerpts
Survival benefit with extended lymphadenectomy for advanced renal malignancy: A population-based analysis.
1
—
—